Repository logo
 

Metabolic control of porin permeability influences antibiotic resistance in Escherichia coli.

Published version
Peer-reviewed

Repository DOI


Change log

Abstract

Porins mediate the passage of hydrophilic nutrients and antibiotics across the outer membrane but might contribute to proton leak from the periplasm, suggesting that their conductance could be regulated. Here we show, using single-cell imaging, that porin permeability in Escherichia coli is controlled by changes in periplasmic H+ and K+ concentration. Conductance through porins increases with low periplasmic H+ caused by starvation, promoting nutrient uptake, and decreases with periplasmic acidification during growth in lipid media, limiting proton loss. High metabolic activity during growth in glucose media, however, activates the inner membrane voltage-gated potassium channel, Kch, increasing periplasmic potassium and enhancing porin permeability to dissipate reactive oxygen species. This metabolic control of porin permeability explains the observed increase in ciprofloxacin resistance of bacteria catabolizing lipids and clarifies the impact of mutations in central metabolism genes on drug resistance, identifying Kch as a therapeutic target to improve bacterial killing by antibiotics.

Description

Acknowledgements: We thank J. Cama and the Keyser Lab (University of Cambridge) for their help with the mother machine master template. We thank E. Derivery (MRC Laboratory of Molecular Biology, Cambridge) for his help with the microfluidics facility. This work was supported by Wellcome Trust grants Investigator award 107032AIA (R.A.F., S.E.C.M, A.H., I.E.E.) and Discovery award 226602/Z/22/Z (R.A.F., S.T., A.H., C.R., F.C.-W.), the UK Cystic Fibrosis Trust Innovation Hub grant 001 (S.E.C.M., A.H., T.L.B., R.A.F.), LifeArc/CF Trust Innovation Hub THUB01 (R.A.F., S.T., A.H., C.R., F.C.-W.) as part of the Translational Innovation Hub Network for CF Lung Health and Infection, the National Institute for Health and Care Research Cambridge Biomedical Research Centre (R.A.F.), Botnar Foundation grant 6063 (S.E.C.M., R.A.F., T.L.B.), Wellcome Trust Award RG89305 (G.H., S.B.), University Startup Award for Lectureship in Synthetic Biology NKXY ISSF3/46 (G.H., S.B.), EPSRC New Investigator Award EP/W032813/1 (G.H., S.B.) seed fund from the School of Technology at University of Cambridge (G.H., S.B.), and BBSRC University of Cambridge Doctoral Training Partnership 2 award BB/M011194/1 (G.H.).

Journal Title

Nat Microbiol

Conference Name

Journal ISSN

2058-5276
2058-5276

Volume Title

10

Publisher

Springer Nature

Rights and licensing

Except where otherwised noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/
Sponsorship
EPSRC (EP/W032813/1)
Biotechnology and Biological Sciences Research Council (BB/M011194/1)
Cystic Fibrosis Trust (IH 001)
Wellcome Trust (226602/Z/22/Z)
Supported by Wellcome Trust grants Investigator award 107032AIA (R.A.F., S.E.C.M, A.H., I.E.E.) and Discovery award 226602/Z/22/Z (R.A.F, ST, AH, CR, FC-W), the UK Cystic Fibrosis Trust Innovation Hub grant 001 (S.E.C.M, A.H., T.L.B., R.A.F.); LifeArc/CF Trust Innovation Hub THUB01 (R.A.F, ST, AH, CR, FC-W) as part of the Translational Innovation Hub Network for CF Lung Health & Infection; the NIHR Cambridge Biomedical Research Centre (R.A.F.); Botnar Foundation grant 6063 (S.E.C.M., R.A.F., T.L.B)